Arcturus Therapeutics Ltd

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Arcturus Therapeutics Ltd
CIK #0001566049, 0001573745
EDGAR Form CIK 2011 - 2026
10-K [0001566049]
10-Q [0001566049]
3 [0001566049]
4 [0001566049]
6-K [0001566049]
8-K [0001566049]
D [0001566049]
SC 13D [0001566049]
SC 13G [0001566049]
D [0001573745]
Form 13D/13G Filer Form 13D/13G Subject Filed
Ark Investment Management LLC Arcturus Therapeutics Ltd [2019-02-14]
Brosh Capital Partners LP Arcturus Therapeutics Ltd [2018-06-11]
Brosh Capital Partners LP Arcturus Therapeutics Ltd [2018-04-30]
Brosh Capital Partners LP Arcturus Therapeutics Ltd [2018-04-09]
Chivukula Pad Arcturus Therapeutics Ltd [2018-02-22]
Broadfin Capital LLC Arcturus Therapeutics Ltd [2018-02-13]
Willett Craig Arcturus Therapeutics Ltd [2018-02-07]
Payne Joseph E Arcturus Therapeutics Ltd [2018-02-06]
Sorenson Bradley T Arcturus Therapeutics Ltd [2018-01-19]
Brosh Capital LP Alcobra Ltd [2017-02-02]
View All
Form 3/4/5 Subject 2011 - 2026
Alcobra Ltd
Chivukula Pad
Kummerfeld Keith C
Payne Joseph E
Marquet Magda
Farrell Peter C
Barlow James F
Sassine Andy
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Alcobra Ltd ARCT
Non-Qualified Stock Option (right to buy) · derivative
2019-02-07 Grant 38,333 $4.99 191,282
Alcobra Ltd ARCT
Incentive Stock Option (right to buy) · derivative
2019-02-07 Grant 1,667 $4.99 8,318
Alcobra Ltd ARCT
Incentive Stock Option (right to buy) · derivative
2019-02-07 Grant 10,000 $4.99 49,900
Alcobra Ltd ARCT
Non-Qualified Stock Option (right to buy) · derivative
2019-02-07 Grant 60,000 $4.99 299,400
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com